Neurothera Labs Inc. Stock Price

TSXV:NTLX Community·CA$14.4m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

NTLX Share Price Performance

CA$0.17

-0.03 (-15.00%)

CA$0.17

-0.03 (-15.00%)

CA$0.17

Thu, 15 Jan 26

Share Pricen/a

NTLX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Slight risk with weak fundamentals.

4 Risks

0 Rewards

View Full Analysis

Neurothera Labs Inc. Key Details

Last Reported Earnings

n/a

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About NTLX

Founded: n/a
Employees: n/a
CEO: n/a
WebsiteView website: www.neurothera.com

Neurothera Labs Inc. operates a clinical-stage pharmaceutical company. The company engaged in the following drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome, for the treatment of Alzheimer's disease and agitation; and SCI- 210 for the treatment of ASD and status epilepticus. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Vancouver, Canada. As of February 23, 2023, Neurothera Labs Inc. operates as a subsidiary of SciSparc Ltd.